Taysha Gene Therapies (TSHA) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for Taysha Gene Therapies (TSHA) over the last 4 years, with Q3 2025 value amounting to $3.2 million.
- Taysha Gene Therapies' Other Gross PP&E Adjustments rose 4352.89% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 4352.89%. This contributed to the annual value of $2.0 million for FY2024, which is 4957.62% down from last year.
- Taysha Gene Therapies' Other Gross PP&E Adjustments amounted to $3.2 million in Q3 2025, which was up 4352.89% from $2.0 million recorded in Q2 2025.
- Taysha Gene Therapies' Other Gross PP&E Adjustments' 5-year high stood at $5.5 million during Q2 2023, with a 5-year trough of $1.4 million in Q1 2025.
- Moreover, its 4-year median value for Other Gross PP&E Adjustments was $3.9 million (2023), whereas its average is $3.8 million.
- Examining YoY changes over the last 5 years, Taysha Gene Therapies' Other Gross PP&E Adjustments showed a top increase of 4352.89% in 2025 and a maximum decrease of 6241.27% in 2025.
- Over the past 4 years, Taysha Gene Therapies' Other Gross PP&E Adjustments (Quarter) stood at $5.3 million in 2022, then dropped by 26.16% to $3.9 million in 2023, then tumbled by 49.58% to $2.0 million in 2024, then skyrocketed by 63.27% to $3.2 million in 2025.
- Its last three reported values are $3.2 million in Q3 2025, $2.0 million for Q2 2025, and $1.4 million during Q1 2025.